Company Search:
Advanced Search
Sponsored Links
10X Genomics Inc Company Snapshot
10X Genomics Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares 10X Genomics Inc with three other companies in this sector in UNITED STATES : Repligen Corporation (2020 sales of $366.26 million of which 48% was Product revenue - Filtration products), Halozyme Therapeutics, Inc. ($267.59 million of which 33% was Royalties), and Denali Therapeutics Inc ($335.66 million of which 100% was Biological Products).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
10X Genomics Inc
  Stock Performance Chart for 10X Genomics Inc
  Stock Data: Recent Stock Performance:
  Current Price (5/7/2021): 146.36
(Figures in U.S. Dollars)
1 Week -26.0%   13 Weeks -24.8%  
4 Weeks -21.1%   52 Weeks 76.4%  
10X Genomics Inc Key Data:
  Ticker: TXG Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2020 Sales 298,845,000
(Year Ending Jan 2021).
Employees: 852
  Currency: U.S. Dollars Market Cap: 16,070,223,938
  Fiscal Yr Ends: December Shares Outstanding: 109,799,289
  Share Type: Common Closely Held Shares: 35,855,954
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.